MaxLinear (NASDAQ:MXL) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $27.25, a high estimate of $28.00, and a low estimate of $25.00. Observing a 4.81% increase, the current average has risen from the previous average price target of $26.00.

Breaking Down Analyst Ratings: A Detailed Examination

A comprehensive examination of how financial experts perceive MaxLinear is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Capture valuable insights into MaxLinear's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on MaxLinear analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Get to Know MaxLinear Better

Unraveling the Financial Story of MaxLinear

Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Challenges: MaxLinear's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -61.65%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.

Net Margin: MaxLinear's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -75.9%, the company may face hurdles in effective cost management.

Return on Equity (ROE): MaxLinear's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -10.92%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): MaxLinear's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -6.85%, the company may face hurdles in achieving optimal financial performance.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.24.

Analyst Ratings: What Are They?

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.